apolipoprotein C2
| UniProt | Protein Name |
|---|---|
| A0A024R0T9 |
|
| P02655 |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| positive regulation of phospholipase activity | ||
| positive regulation of triglyceride catabolic process | ||
| positive regulation of very-low-density lipoprotein particle remodeling | ||
| negative regulation of very-low-density lipoprotein particle clearance | ||
| lipid catabolic process |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region | ||
| extracellular region | ||
| extracellular space | ||
| early endosome | ||
| very-low-density lipoprotein particle |
| GO Term | Evidence Code | PMID |
|---|---|---|
| protein binding | ||
| lipid binding | ||
| phospholipase activator activity | ||
| phospholipase activator activity | ||
| identical protein binding |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0111418 | familial apolipoprotein C-II deficiency | |
| DOID:1168 | familial hyperlipidemia | |
| DOID:2377 | multiple sclerosis |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026